BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34576152)

  • 1. Aryl Hydrocarbon Receptor Defect Attenuates Mitogen-Activated Signaling through Leucine-Rich Repeats and Immunoglobulin-like Domains 1 (LRIG1)-Dependent EGFR Degradation.
    Hsu HL; Chen HK; Tsai CH; Liao PL; Chan YJ; Lee YC; Lee CC; Li CH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Cover: High Susceptibility of Lrig1 Sebaceous Stem Cells to TCDD in Mice.
    Fontao F; Barnes L; Kaya G; Saurat JH; Sorg O
    Toxicol Sci; 2017 Dec; 160(2):230-243. PubMed ID: 28973660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1.
    Yi W; Holmlund C; Nilsson J; Inui S; Lei T; Itami S; Henriksson R; Hedman H
    Exp Cell Res; 2011 Feb; 317(4):504-12. PubMed ID: 21087604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aryl hydrocarbon receptor suppresses cigarette-smoke-induced oxidative stress in association with dioxin response element (DRE)-independent regulation of sulfiredoxin 1.
    Sarill M; Zago M; Sheridan JA; Nair P; Matthews J; Gomez A; Roussel L; Rousseau S; Hamid Q; Eidelman DH; Baglole CJ
    Free Radic Biol Med; 2015 Dec; 89():342-57. PubMed ID: 26408075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.
    Wei Y; Liu X; Jiang Y; Guan Q; Tian Y; Li J; Zhao P
    Phytomedicine; 2023 Sep; 118():154980. PubMed ID: 37499344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RelB attenuates cigarette smoke extract-induced apoptosis in association with transcriptional regulation of the aryl hydrocarbon receptor.
    Iu M; Zago M; Rico de Souza A; Bouttier M; Pareek S; White JH; Hamid Q; Eidelman DH; Baglole CJ
    Free Radic Biol Med; 2017 Jul; 108():19-31. PubMed ID: 28254546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells.
    Zhang X; Song Q; Wei C; Qu J
    Cell Stress Chaperones; 2015 Jul; 20(4):631-41. PubMed ID: 25860915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance.
    Billing O; Holmgren Y; Nosek D; Hedman H; Hemmingsson O
    Oncogene; 2021 May; 40(21):3707-3718. PubMed ID: 33947959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation.
    Xie G; Peng Z; Raufman JP
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1006-15. PubMed ID: 22361730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development.
    Lu L; Teixeira VH; Yuan Z; Graham TA; Endesfelder D; Kolluri K; Al-Juffali N; Hamilton N; Nicholson AG; Falzon M; Kschischo M; Swanton C; Wright NA; Carroll B; Watt FM; George JP; Jensen KB; Giangreco A; Janes SM
    J Pathol; 2013 Mar; 229(4):608-20. PubMed ID: 23208928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
    Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
    Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of the AhR in chronic obstructive pulmonary disease (COPD)-derived lung cells increases COX-2 protein by altering mRNA stability.
    Zago M; Sheridan JA; Traboulsi H; Hecht E; Zhang Y; Guerrina N; Matthews J; Nair P; Eidelman DH; Hamid Q; Baglole CJ
    PLoS One; 2017; 12(7):e0180881. PubMed ID: 28749959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
    Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C
    J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
    Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
    J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.
    Torigoe H; Yamamoto H; Sakaguchi M; Youyi C; Namba K; Sato H; Shien K; Soh J; Suzawa K; Tomida S; Tsukuda K; Miyoshi S; Toyooka S
    Carcinogenesis; 2018 May; 39(5):719-727. PubMed ID: 29546323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM17 and EGFR regulate IL-6 receptor and amphiregulin mRNA expression and release in cigarette smoke-exposed primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD).
    Stolarczyk M; Amatngalim GD; Yu X; Veltman M; Hiemstra PS; Scholte BJ
    Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27561911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.
    Luecke-Johansson S; Gralla M; Rundqvist H; Ho JC; Johnson RS; Gradin K; Poellinger L
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
    Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
    Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of LRIG1, a Negative Regulator of EGFR, Is Dynamically Altered during Different Stages of Gastric Carcinogenesis.
    Yu S; Yang M; Lim KM; Cho Y; Kim H; Lee K; Jeong SH; Coffey RJ; Goldenring JR; Nam KT
    Am J Pathol; 2018 Dec; 188(12):2912-2923. PubMed ID: 30248341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.